Prices of biologicals in EU

With this study, we aimed to compare the retail prices of biological DMARDs approved for the treatment of rheumatoid arthritis and to identify possible differences in affordability between European countries.

Publication Details

Journal
Open Science Framework
Published
2025-01-01
DOI
https://doi.org/10.17605/osf.io/rgqne
Primary Topic
Rheumatoid Arthritis Research and Therapies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Prices of biologicals in EU

Open Science Framework
Rheumatoid Arthritis Research and Therapies
article

Prices of biologicals in EU

article en

Abstract

With this study, we aimed to compare the retail prices of biological DMARDs approved for the treatment of rheumatoid arthritis and to identify possible differences in affordability between European countries.

Open Science Framework
Openalex Percentile: Top 42%
Rheumatoid Arthritis Research and Therapies
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Prices of biologicals in EU · Open Science Framework (2025) | TGRS Research Map | TGRS